+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Paraneoplastic syndromes in patients with laryngeal neuroendocrine carcinomas: clinical manifestations and prognostic significance



Paraneoplastic syndromes in patients with laryngeal neuroendocrine carcinomas: clinical manifestations and prognostic significance



European Archives of Oto-Rhino-Laryngology 273(3): 533-536



Paraneoplastic syndromes are associated with a variety of malignant neoplasms and are systemic and non-metastatic manifestations that develop in a minority of cancer patients. This review examines all published cases of paraneoplastic syndromes associated with neuroendocrine carcinomas of the larynx. There are a total of ten patients reported with paraneoplastic syndromes associated with laryngeal neuroendocrine carcinomas in the literature. Of these, nine died and the tenth is alive with liver metastases. There were five cases of small-cell neuroendocrine carcinoma, four cases of moderately differentiated neuroendocrine carcinoma, and one case of well-differentiated neuroendocrine carcinoma associated with paraneoplastic syndromes. As these syndromes have significant clinical relevance, physicians should be aware of the possible presence of paraneoplastic syndromes in the diagnostic process of patients with neuroendocrine carcinoma of the larynx.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054862760

Download citation: RISBibTeXText

PMID: 25351497

DOI: 10.1007/s00405-014-3351-5


Related references

Paraneoplastic syndromes (PNS) associated with Merkel cell carcinoma (MCC): A case series of 8 patients highlighting different clinical manifestations. Journal of the American Academy of Dermatology 75(3): 541-547, 2016

Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications. Clinical Cancer Research 2(1): 175-180, 1996

The incidence and clinical significance of paraneoplastic syndromes in patients with hepatocellular carcinoma. Korean Journal of Hepatology 11(3): 275-283, 2005

Prognostic role and significance of paraneoplastic syndromes in hepatocellular carcinoma. American Surgeon 80(2): 191-196, 2014

Endocrine paraneoplastic syndromes in patients with neuroendocrine neoplasms. Endocrine 64(2): 384-392, 2019

Paraneoplastic syndromes in patients with laryngeal and hypopharyngeal cancers. Annals of Otology, Rhinology, and Laryngology 109(1): 109-117, 2000

Prognostic significance of neuroendocrine cells in colorectal carcinomas. Journal of Cancer Research & Clinical Oncology 116(Suppl. Part 1): 656, 1990

Prognostic significance of neuroendocrine components in gastric carcinomas. European Journal of Cancer 50(16): 2802-2809, 2014

Neuroendocrine differentiation in colorectal carcinomas: assessing its prognostic significance. Tumori 89(1): 49-53, 2003

Prevalence and Prognostic Significance of Neuroendocrine Differentiation in Colorectal Carcinomas. Endocrine Pathology 9(1): 35-42, 1998

Clinical significance of paraneoplastic syndromes. Vnitrni Lekarstvi 35(3): 237-241, 1989

Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance. Human Pathology 36(7): 732-740, 2005

Prognostic significance of cyclin E overexpression in laryngeal squamous cell carcinomas. Clinical Cancer Research 6(11): 4253-4258, 2000

Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas. Clinical Cancer Research 11(1): 259-266, 2005

Nuclear morphometry and its prognostic significance in laryngeal squamous cell carcinomas. Chinese Medical Journal 105(5): 410-414, 1992